| Ted Edwards, DO | |
|
2700 Triana Blvd, Huntsville, AL 35805 | |
| (256) 885-9708 | |
| (256) 883-1840 |
| Full Name | Ted Edwards |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 31 Years |
| Location | 2700 Triana Blvd, Huntsville, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932189560 | NPI | - | NPPES |
| 009913555 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | DO-778 (Alabama) | Primary |
| 174400000X | Specialist | DO-778 (Alabama) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rehabilitation And Neurological Services Llc | 9234156027 | 3 |
News Archive
Recent initiatives in global health have made significant advances in knowledge, prevention and reduction of diseases affecting children in low-income countries.
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Cancer Research Technology (CRT), the specialist oncology development and commercialisation company, and Stealthyx Therapeutics, the disease targeting drug company spin out of Queen Mary, University of London have entered into an agreement to co-develop Stealthyx's proprietary drug delivery platform, Prothyx.
IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, announced today the launch of its new and improved corporate website at www.proiris.com, featuring a newly designed homepage and enhanced navigation tools with access to the latest company information.
A new study in the American Journal of Gastroenterology examined the recently set Guidelines regarding the treatment and management of osteoporosis in patients with Inflammatory Bowel Disease (IBD), and found that they are effective.
› Verified 8 days ago
| Entity Name | Rehabilitation & Neurological Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548240179 PECOS PAC ID: 9234156027 Enrollment ID: O20051101000024 |
News Archive
Recent initiatives in global health have made significant advances in knowledge, prevention and reduction of diseases affecting children in low-income countries.
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Cancer Research Technology (CRT), the specialist oncology development and commercialisation company, and Stealthyx Therapeutics, the disease targeting drug company spin out of Queen Mary, University of London have entered into an agreement to co-develop Stealthyx's proprietary drug delivery platform, Prothyx.
IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, announced today the launch of its new and improved corporate website at www.proiris.com, featuring a newly designed homepage and enhanced navigation tools with access to the latest company information.
A new study in the American Journal of Gastroenterology examined the recently set Guidelines regarding the treatment and management of osteoporosis in patients with Inflammatory Bowel Disease (IBD), and found that they are effective.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ted Edwards, DO 2700 Triana Blvd, Huntsville, AL 35805 Ph: (256) 885-9708 | Ted Edwards, DO 2700 Triana Blvd, Huntsville, AL 35805 Ph: (256) 885-9708 |
News Archive
Recent initiatives in global health have made significant advances in knowledge, prevention and reduction of diseases affecting children in low-income countries.
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Cancer Research Technology (CRT), the specialist oncology development and commercialisation company, and Stealthyx Therapeutics, the disease targeting drug company spin out of Queen Mary, University of London have entered into an agreement to co-develop Stealthyx's proprietary drug delivery platform, Prothyx.
IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, announced today the launch of its new and improved corporate website at www.proiris.com, featuring a newly designed homepage and enhanced navigation tools with access to the latest company information.
A new study in the American Journal of Gastroenterology examined the recently set Guidelines regarding the treatment and management of osteoporosis in patients with Inflammatory Bowel Disease (IBD), and found that they are effective.
› Verified 8 days ago
Ronald L Collins, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Governors Dr Sw Ste 400, Huntsville, AL 35801 Phone: 256-265-7246 Fax: 256-265-7017 |